Trials / Completed
CompletedNCT00604071
Sensitivity of the Home Macular Perimeter (HMP)
Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Notal Vision Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
estimate the sensitivity of the HMP test in identifying visual field functional defects in subjects with CNV secondary to AMD
Detailed description
The HMP device is intended to aid patients in identifying their visual abnormalities and in addition to their own symptoms or Amsler grid use and aid in their prompt referral to eye care professional examination so clinical diagnosis can be made. As such the goal of the clinical plan is to demonstrate that patients who have CNV do demonstrate visual field abnormalities when tested with the HMP
Conditions
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Completion
- 2008-11-01
- First posted
- 2008-01-29
- Last updated
- 2015-04-14
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00604071. Inclusion in this directory is not an endorsement.